Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6D2U

Solution structure of a ultra-high affinity macrocycle bound to HIV-1 TAR RNA

6D2U の概要
エントリーDOI10.2210/pdb6d2u/pdb
NMR情報BMRB: 30452
分子名称DAB-VAL-ARG-THR-ARG-LYS-GLY-ARG-ARG-ILE-NOR-ILE-DPR-PRO, RNA (29-MER) (2 entities in total)
機能のキーワードmacrocycle inhibitor, complex, hiv-1 tar, tat, p-tefb, rna, peptide-rna complex, peptide/rna
由来する生物種synthetic construct
詳細
タンパク質・核酸の鎖数2
化学式量合計11004.64
構造登録者
Shortridge, M.D.,Varani, G. (登録日: 2018-04-13, 公開日: 2018-12-12, 最終更新日: 2023-11-15)
主引用文献Shortridge, M.D.,Wille, P.T.,Jones, A.N.,Davidson, A.,Bogdanovic, J.,Arts, E.,Karn, J.,Robinson, J.A.,Varani, G.
An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.
Nucleic Acids Res., 47:1523-1531, 2019
Cited by
PubMed Abstract: The HIV-1 trans-activator protein Tat binds the trans-activation response element (TAR) to facilitate recruitment of the super elongation complex (SEC) to enhance transcription of the integrated pro-viral genome. The Tat-TAR interaction is critical for viral replication and the emergence of the virus from the latent state, therefore, inhibiting this interaction has long been pursued to discover new anti-viral or latency reversal agents. However, discovering active compounds that directly target RNA with high affinity and selectivity remains a significant challenge; limiting pre-clinical development. Here, we report the rational design of a macrocyclic peptide mimic of the arginine rich motif of Tat, which binds to TAR with low pM affinity and 100-fold selectivity against closely homologous RNAs. Despite these unprecedented binding properties, the new ligand (JB181) only moderately inhibits Tat-dependent reactivation in cells and recruitment of positive transcription elongation factor (P-TEFb) to TAR. The NMR structure of the JB181-TAR complex revealed that the ligand induces a structure in the TAR loop that closely mimics the P-TEFb/Tat1:57/AFF4/TAR complex. These results strongly suggest that high-affinity ligands which bind the UCU bulge are not likely to inhibit recruitment of the SEC and suggest that targeting of the TAR loop will be an essential feature of effective Tat inhibitors.
PubMed: 30481318
DOI: 10.1093/nar/gky1197
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 6d2u
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon